Xiao et al. 19 found that Tim‐3 was significantly elevated on both CD4+ and CD8+ T cells in diffuse large B cell lymphoma patients than in healthy controls. This evidence concerns the gene HAVCR2 and diffuse large B-cell lymphoma.